Produktbild: Advanced Vaccination Technologies for Infectious and Chronic Diseases
- 19%

Advanced Vaccination Technologies for Infectious and Chronic Diseases A guide to Vaccinology

19% sparen

134,99 € UVP 167,50 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

28.03.2024

Herausgeber

Vasso Apostolopoulos + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

528

Maße (L/B/H)

21,2/27,4/2,9 cm

Gewicht

1400 g

Sprache

Englisch

ISBN

978-0-443-18564-9

Beschreibung

Portrait

Professor Vasso Apostolopoulos is a Distinguished Professor at RMIT University, Australia. She received her PhD in immunology in 1995 from the University of Melbourne and the Advanced Certificate in Protein Crystallography from Birkbeck College, University of London. Professor Vasso Apostolopoulos is a world-renowned researcher who has been recognized with over 100 awards for the outstanding results of her research. She has published over 500 research publications, 8 books, and 33 book chapters, is a sought-after keynote speaker at conferences, is an inventor on 21 patents, and has over 22,000 citations.

Dr. Lalitkumar K. Vora is a Lecturer at the School of Pharmacy, Queen’s University, Belfast, and was included in Stanford's top 2% of world scientists list in 2023.

Vivek P. Chavda is an Assistant Professor (Selection Grade) in the Department of Pharmaceutics and Pharmaceutical Technology at L. M. College of Pharmacy, Ahmedabad, Gujarat, India. He earned Bachelor and Master of Pharmacy degrees and was a Gold Medallist at Gujarat Technological University. Before entering academia, he spent several years in the Biologics industry, contributing to R&D and regulatory filings for biologics. His scholarly output includes numerous peer‑reviewed articles, several books and book chapters, and ongoing writings in newsletters. His research spans the development of biologics processes and formulations, medical device development, nano diagnostics and noncarrier formulations, long-acting parenteral formulations, and nano vaccines. He also has patent assets in development and a record of industry-focused publications.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

28.03.2024

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

528

Maße (L/B/H)

21,2/27,4/2,9 cm

Gewicht

1400 g

Sprache

Englisch

ISBN

978-0-443-18564-9

EU-Ansprechpartner

Zeitfracht Medien GmbH
Ferdinand-Jühlke-Straße 7
99095 Erfurt
DE
produktsicherheit@zeitfracht.de

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben: Einfach Barcode scannen, Versandetikett ausdrucken, Bücher verschicken und Thalia Geschenkkarte erhalten.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Advanced Vaccination Technologies for Infectious and Chronic Diseases
  • 1: History of Vaccination
    2: Vaccine Adjuvants and carriers
    3: Conventional vaccination methods: Inactivated and Live attenuated vaccines
    4: Subunit protein based Vaccines
    5: Peptide based vaccines and altered peptide ligands: Multiple Sclerosis paving the way
    6: Vector based vaccine delivery and associated immunity: Current Status and Way Forward
    7: It's all about the delivery: How to augment the efficiency of DNA vaccination
    8: Plant-based biotechnological vaccines for emerging infectious diseases
    9: Expression system and purification process for the vaccine production
    10: Targeting dendritic cells for antigen delivery for vaccine design
    11: Parenteral Vaccine delivery: from basic principles to new developments
    12: Mucosal Vaccine delivery
    13: Personalized vaccines, novel vaccination technologies and future prospects
    14: The application of nanoparticle-based delivery systems in vaccine development
    15: Preclinical and clinical development for vaccines and formulations
    16: Regulatory processes involved in clinical trials and IPR around vaccine development
    17: Vaccine safety, efficacy, and ethical considerations
    18: Regulatory consideration and pathways for vaccine development
    19: New approaches to vaccines for infectious diseases
    20: New approaches to vaccines for cancer
    21: New approaches to vaccines for autoimmunity
    22: The fast-track development COVID-19 vaccines
    23: Myths and Facts about Vaccination: Dispelling Myths and Misconceptions with Science
    24: Proteogenomics and immunopeptidomics in the development of advanced vaccines
    25: Future Vaccine Technologies